ArticleslgStudy

chemistry

Pacritinib

Pacritinib is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Pacritinib rather than just read about it. In short: Pacritinib, sold under the brand name Vonjo, is an anti-cancer medication used to treat myelofibrosis. It is a macrocyclic protein kinase inhibitor.

Pacritinib — main illustration
Pacritinib — illustration

Key takeaways

  • Pacritinib belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Pacritinib to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Pacritinib from memory before moving on to harder problems.

Reference excerpt

Pacritinib, sold under the brand name Vonjo, is an anti-cancer medication used to treat myelofibrosis. It is a macrocyclic protein kinase inhibitor. It mainly inhibits Janus kinase 2 (JAK2) and Fms-like tyrosine kinase 3\CD135 (FLT3). Common side effects include diarrhea, low platelet counts, nausea, anemia, and swelling in legs.

Medical uses Pacritinib in indicated to treat adults who have a rare form of a bone marrow disorder known as intermediate or high-risk primary or secondary myelofibrosis and who have platelet (blood clotting cells) levels below 50,000/μL.

History The effectiveness and safety of pacritinib were demonstrated in a study that included 63 participants with intermediate or high-risk primary or secondary myelofibrosis and low platelets who received pacritinib 200 mg twice daily or standard treatment. Effectiveness was determined based upon the proportion of participants who had a 35% or greater spleen volume reduction from baseline to week 24. Nine participants (29%) in the pacritinib treatment group had a 35% or greater spleen volume reduction, compared to one participant (3%) in the standard treatment group. The U.S. Food and Drug Administration (FDA) granted the application for pacritinib priority review, fast track, and orphan drug designations.

Society and culture

Names Pacritinib is the International nonproprietary name (INN).

References

External links "Pacritinib". Drug Information Portal. U.S. National Library of Medicine. Archived from the original on 21 October 2020.

Illustrations

Pacritinib illustration

Worked examples

Example 1 — a first encounter with Pacritinib

Start with the simplest possible case. Write down what Pacritinib claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Pacritinib before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Pacritinib ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Pacritinib

In research
Pacritinib appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Pacritinib in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Pacritinib is common in secondary-school and first-year university syllabi. It links to neighbouring topics 1-Pyrrolidinyl compounds, Aminopyrimidines, Antineoplastic and immunomodulating drug stubs, so understanding it makes those chapters shorter.
In everyday life
Look for Pacritinib outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Pacritinib in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Pacritinib means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Pacritinib out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Pacritinib in simple terms?

Pacritinib, sold under the brand name Vonjo, is an anti-cancer medication used to treat myelofibrosis. It is a macrocyclic protein kinase inhibitor.

Why does Pacritinib matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Pacritinib?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Pacritinib.

Tags

  • 1-Pyrrolidinyl compounds
  • Aminopyrimidines
  • Antineoplastic and immunomodulating drug stubs
  • Antineoplastic drugs
  • Biaryls
  • Ethanolamines
  • Ethers
  • Nitrogen heterocycles
  • Non-receptor tyrosine kinase inhibitors
  • Orphan drugs
  • Oxygen heterocycles

Keep exploring